Assessment of smoking status in patients with peripheral arterial disease

Journal of Vascular Surgery

Volumn 41, Issue 3, 2005, Pages 451-456

  Hobbs, Simon D ^a   Wilmink, Antonius B M ^a   Adam, Donald J ^a   Bradbury, Andrew W ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; COTININE; CREATININE;

ADULT; AGED; ANAMNESIS; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; ASSAY; BREATHING; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; EXHALATION; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; LABORATORY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OUTCOMES RESEARCH; OUTPATIENT DEPARTMENT; PATIENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; SMOKING; SURGICAL WARD; TEACHING HOSPITAL; URINALYSIS; URINE LEVEL;

EID: 17144407563     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2004.12.039     Document Type: Article

References (22)

1. W.B. Kannel, D. Shurtleff The Framingham Study. Cigarettes and the development of intermittent claudication Geriatrics 28 1973 61 68
2. C.W. Cole, G.B. Hill, E. Farzad, A. Bouchard, D. Moher, K. Rody Cigarette smoking and peripheral arterial occlusive disease Surgery 114 1993 753 757
3. S.D. Hobbs, A.W. Bradbury Smoking cessation strategies in patients with peripheral arterial disease an evidence based approach Eur J Vasc Endovasc Surg 26 2003 341 347
4. F.G.R. Fowkes, E. Housley, R.A. Riemersma, C.C.A. Macintyre, E.H.H. Cawood, R.J. Prescott Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischaemic heart disease in the Edinburgh Artery Study Am J Epidemiol 135 1992 331 340
5. A.T. Hirsch, D. Treat-Jacobson, H.A. Lando, D.K. Hatsukami The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease Vasc Med 2 1997 243 251
6. T. Jonason, R. Bergstrom Cessation of smoking in patients with intermittent claudication Acta Med Scand 221 1987 253 260
7. A.W. Gardner The effect of cigarette smoking on exercise capacity in patients with intermittent claudication Vasc Med 1 1996 181 186
8. P.A. Stonebridge, A.W. Bradbury, J.A. Murie Continued smoking and the results of vascular reconstruction Br J Surg 81 1994 51 52
9. C.S. Carty, M. Huribal, B.U. Marsan, J.J. Ricotta, M. Dryjski Nicotine and its metabolite cotinine are mitogenic for human vascular smooth muscle cells J Vasc Surg 25 1997 682 688
10. K.W. Faulkner, A.K. House, W.M. Castleden The effect of cessation of smoking on the accumulative survival rates of patients with symptomatic peripheral vascular disease Med J Aust 1 1983 217 219
11. National Institute for Clinical Excellence. Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation. Technology appraisal guidance No. 39. National Institute for Clinical Excellence. Available at: URL: http://www.nice.org.uk. Accessed February 16, 2002.
12. P.J. Burns, E. Lima, A.W. Bradbury Second best medical therapy Eur J Vasc Endovasc Surg 24 2002 400 404
13. J. Hald, J. Overgaard, C. Grau Evaluation of objective measures of smoking status--a prospective clinical study in a group of head and neck cancer patients treated with radiotherapy Acta Oncol 42 2003 154 159
14. G.C. Leng, F.G.R. Fowkes The Edinburgh Claudication Questionnaire an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys J Clin Epidemiol 45 1992 1101 1109
15. E.T. Middleton, A.H. Morice Breath carbon monoxide as an indication of smoking habit Chest 117 2000 758 763
16. G. Cope, P. Nayyar, R. Holder, J. Gibbons, R. Bunce A simple near-patient test for nicotine and its metabolites in urine to assess smoking habit Clin Chim Acta 256 1996 135 149
17. S.G. Thompson, R.D. Barlow, N.J. Wald, H. Van Vunakis How should urinary cotinine concentrations be adjusted for urinary creatinine concentration? Clin Chim Acta 187 1990 289 296
18. K. Jamrozik, M. Vessey, G. Fowler, N. Wald, G. Parker, H. Van Vunakis Controlled trial of three different antismoking interventions in general practice BMJ 288 1984 1499 1503
19. N.L. Risser, D.W. Belcher Adding spirometry, carbon monoxide and pulmonary symptom results to smoking cessation counselling a randomised trial J Gen Intern Med 5 1990 16 22
20. J.B. McClure Are biomarkers useful treatment aids for promoting health behaviour change?. An empirical review Am J Prev Med 22 2002 200 207
21. S. Sato, K. Nishimura, H. Koyama, M. Tsukino, T. Oga, T. Hajiro Optimal cutoff level of breath carbon monoxide for assessing smoking status in patients with asthma and COPD Chest 124 2003 1749 1754
22. M.J. Jarvis, H. Tunstall-Pedoe, C. Feyerabend, C. Vesey, Y. Saloojee Comparison of tests used to distinguish smokers from non-smokers Am J Public Health 77 1987 1435 1438